205 related articles for article (PubMed ID: 22071579)
1. TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas.
Lino-Silva LS; Flores-Gutiérrez JP; Vilches-Cisneros N; Domínguez-Malagón HR
Virchows Arch; 2011 Dec; 459(6):615-21. PubMed ID: 22071579
[TBL] [Abstract][Full Text] [Related]
2. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma.
Madakshira MG; Radotra BD; Kaman L; Saikia UN
Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590
[TBL] [Abstract][Full Text] [Related]
3. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.
Lan T; Chen H; Xiong B; Zhou T; Peng R; Chen M; Ye F; Yao J; He X; Wang Y; Zhang H
Diagn Pathol; 2016 Jul; 11(1):62. PubMed ID: 27401493
[TBL] [Abstract][Full Text] [Related]
4. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.
Rekhi B; Basak R; Desai SB; Jambhekar NA
Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123
[TBL] [Abstract][Full Text] [Related]
6. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
Valente AL; Tull J; Zhang S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
[TBL] [Abstract][Full Text] [Related]
7. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
9. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics.
Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S
Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625
[TBL] [Abstract][Full Text] [Related]
10. [Application of TLE1 expression and fluorescence in-situ hybridization in diagnosing poorly differentiated synovial sarcoma].
Mao RJ; Li QM; Fang HQ; Han FL; Huang XF; Wu YX; Zeng M
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):403-5. PubMed ID: 21914350
[No Abstract] [Full Text] [Related]
11. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
Foo WC; Cruise MW; Wick MR; Hornick JL
Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
[TBL] [Abstract][Full Text] [Related]
13. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.
Bakrin IH; Hussain FA; Tuan Sharif SE
Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668
[TBL] [Abstract][Full Text] [Related]
14. Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China.
Li Y; Zhang X; Wang A; Ding S; Li Y; Wang H; Lv Y; Shi H
Int J Clin Exp Pathol; 2019; 12(1):251-258. PubMed ID: 31933740
[TBL] [Abstract][Full Text] [Related]
15. TLE1 expression in malignant mesothelioma.
Matsuyama A; Hisaoka M; Iwasaki M; Iwashita M; Hisanaga S; Hashimoto H
Virchows Arch; 2010 Nov; 457(5):577-83. PubMed ID: 20857142
[TBL] [Abstract][Full Text] [Related]
16. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall.
Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM
Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396
[TBL] [Abstract][Full Text] [Related]
17. The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma.
Rooper LM; Sharma R; Gocke CD; Belchis DA
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):174-179. PubMed ID: 28800015
[TBL] [Abstract][Full Text] [Related]
18. Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data.
Klebe S; Prabhakaran S; Hocking A; Pulford E; Moore S; Nicola M; Allen PW; Henderson DW
Pathology; 2018 Oct; 50(6):629-634. PubMed ID: 30170702
[TBL] [Abstract][Full Text] [Related]
19. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
[TBL] [Abstract][Full Text] [Related]
20. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]